Capital Asset Advisory Services LLC Galapagos Nv Transaction History

Capital Asset Advisory Services LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$52.17 - $70.2 $290,117 - $390,382	-5,561 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$68.86 - $83.34 $97,987 - $118,592	-1,423 Reduced 20.38%	5,561 $383,000
Q1 2021 May 13, 2021	BUY	$76.15 - $111.94 $88,867 - $130,633	1,167 Added 20.06%	6,984 $538,000
Q4 2020 Mar 02, 2021	BUY	$96.85 - $148.25 $336,456 - $515,020	3,474 Added 148.27%	5,817 $576,000
Q3 2020 Nov 18, 2020	BUY	$122.47 - $213.56 $42,742 - $74,532	349 Added 17.5%	2,343 $332,000

Q2 2020 Aug 14, 2020	BUY	$185.52 - $231.25 $45,452 - $56,656	245 Added 14.01%	1,994 $370,000
Q1 2020 May 18, 2020	BUY	$143.0 - $274.03 $33,891 - $64,945	237 Added 15.67%	1,749 $388,000
Q4 2019 Feb 13, 2020	BUY	$146.12 - $215.82 $219,326 - $323,945	1,501 Added 13645.45%	1,512 $388,000
Q4 2019 Feb 12, 2020	BUY	$146.12 - $215.82 $1,607 - $2,374	11 New	11 $378,000

16.5M

77.1K

57.2K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.65B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Capital Asset Advisory Services LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Asset Advisory Services LLC with notifications on news.